EUCTR2021-001332-26-ES进行中（未招募）1 期
Clinical effectiveness and bacteriological eradication of 3 short-course antibiotic regimens and single-dose of fosfomicyn trometamol for lower urinary tract infections in adult women [SCOUT study]. - SCOUT
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- Women of 18 years of age or older, with clinical features of uncomplicated community-acquired LUTI including:
- •(1) at least one of four key symptoms of LUTI: dysuria, urgency including nocturia, frequency, and/or suprapubic tenderness that could be attributed to an uncomplicated LUTI, and no alternative explanation (i.e. symptoms suggestive of
- •sexually-transmitted infection or vulvovaginitis), and
- •(2) a urine dipstick analysis positive for either nitrites or leukocyte esterase.
- •-Agree to participate in the clinical trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 800
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •- Male sex.
- •- Clear signs of (i.e. high fever = 38.5°C or flank pain/tenderness) or high suspicion of pyelonephritis.
- •- Symptoms correlating with differential diagnosis (i.e. vaginal discharge or pain).
- •- Any condition that may lead or predispose to complicated urinary infection (i.e. indwelling urinary catheter, pregnancy, immunosuppressive therapy, abnormal urinary tracts, recurrent UTI, severe neurological disease affecting the bladder).
- •- Pregnancy or lactation.
- •- Symptoms consistent with UTI in the preceding 4 weeks.
- •- Patients taking long-term antibiotic prophylaxis.
- •- Ongoing antibiotic therapy or use of any antibiotics in the previous 7 days.
- •- Hypersensitivity or allergy to penicillins, nitrofurantoin and/or fosfomycin.
- •- Moderate to severe chronic renal insufficiency (stage III or higher).
- •- Pre-existing polyneuropathy.
- •- History of lung or liver reaction or peripheral neuropathy after previous use of nitrofurantoin.
- •- Glucose-6-phosphate dehydrogenase deficiency.
- •- Porphyria or systemic primary carnitine deficiency or of the type organic aciduria (i.e. methylmalonic aciduria and propionacidanaemia).
- •- Oesophageal stricture.
- •- Current intake of allopurinol (i.e. increases the risk of allergic skin reaction to mecillinam) or probenecid (i.e. decreases the renal excretion of mecillinam) or valproate.
- •- Currently part of another clinical trial.
- •- Previous enrolment in the SCOUT study.
- •- Inability/unable to understand and/or take part in the clinical trial.
- •- Active neoplasia
- •- Terminal illness.
- •- Institutionalized patients
- •- Difficulty to perform the follow-up visits.
研究者
相似试验
已完成
2 期
A novel drug to treat gum diseases.CTRI/2019/05/019477Dayananda Sagar College of Dental Sciences26
尚未招募
Unknown
Comparison of Efficacy of SRP Alone & in Combination with LDD & Mouthwash in patients with PeriodontitisCTRI/2023/07/055061SGT UNIVERSITY
尚未招募
2 期
Clinical and microbiological evaluation after treatment at the site of chronic periodontal disease, with gels containing antimicrobial agentsRBR-226f6jFaculdade De Odontologia de Ribeirão Preto
进行中（未招募）
1 期
Clinical Study Toothpaste base Rosemary on Plaque and Saliva BacteriumRBR-9f3ctbFPE-Universidade Federal de Pernambuco
尚未招募
不适用
Comparison of the anti bacterial property of octenidine and chlorhexidine mouthwash in periodontitis patientsCTRI/2022/12/048377Dr Samistha Sinha